Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase NA 1

Status

Terminated 2Recruiting 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 2

Conditions

Glioma 2Recurrence 1Glioblastoma 1

Interventions

Cyclophosphamide 98pembrolizumab 85Gemcitabine 81Carboplatin 62fludarabine 61Nivolumab 57Cisplatin 54Paclitaxel 51Radiotherapy 50Docetaxel 49Rituximab 46Dexamethasone 42Lenalidomide 41Ipilimumab 38Azacitidine 35Etoposide 34Cytarabine 33Temozolomide 32Bevacizumab 32Radiation 29venetoclax 28Bortezomib 27Magnetic Resonance Spectroscopy 26Irinotecan 26Pemetrexed 25atezolizumab 24Oxaliplatin 24Capecitabine 24fludarabine phosphate 22Filgrastim 22

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1 × Terminated × fluorodopa F 18 × Clear all
NCT02176720 2018-08-17

Response Monitoring Trial in Patients With Suspected Recurrence of Glioblastoma

The Methodist Hospital Research Institute

Phase 1 Terminated
31 enrolled
CNS

Glioblastoma, Glioma, Recurrence

NCT02371031 2016-11-30

FDOPA-PET/MRI for the Pre-operative Evaluation of Gliomas

Washington University School of Medicine

Phase 1 Terminated
11 enrolled
CNS

Glioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡